Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$109.46 USD
+2.03 (1.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $109.54 +0.08 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Earnings News For JAZZ
-
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report?
-
Jazz (JAZZ) Q3 Earnings Lag, Revenues in Line With Estimates
-
Jazz: Q4 Earnings Snapshot
-
Jazz: Q4 Earnings Snapshot
-
Jazz Pharmaceuticals (JAZZ) Q4 Earnings Lag Estimates
-
Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?
-
Jazz (JAZZ) Lags Q3 Earnings, Beats Sales, Raises '23 View
-
Jazz: Q3 Earnings Snapshot
-
Jazz Pharmaceuticals (JAZZ) Expected to Beat Earnings Estimates: Should You Buy?
-
Why Is Jazz (JAZZ) Up 0.4% Since Last Earnings Report?
-
Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View
-
Jazz Pharmaceuticals (JAZZ) Q2 Earnings and Revenues Top Estimates
-
Jazz: Q2 Earnings Snapshot
-
Jazz Pharmaceuticals (JAZZ) to Report Q2 Results: Wall Street Expects Earnings Growth
-
Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?
-
Jazz (JAZZ) Lags on Q1 Earnings & Sales, Reaffirms '23 View
-
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates
-
Jazz: Q1 Earnings Snapshot
-
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Q1 Release
-
Jazz (JAZZ) Up 0.4% Since Last Earnings Report: Can It Continue?
-
Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales
-
Jazz: Q4 Earnings Snapshot
-
Jazz Pharmaceuticals (JAZZ) Reports Q4 Loss, Misses Revenue Estimates
-
Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for